Edition:
United Kingdom

Dare Bioscience Inc (DARE.OQ)

DARE.OQ on NASDAQ Stock Exchange Capital Market

2.54USD
12 Dec 2017
Change (% chg)

$0.03 (+1.20%)
Prev Close
$2.51
Open
$2.49
Day's High
$2.54
Day's Low
$2.45
Volume
3,136
Avg. Vol
6,580
52-wk High
$35.70
52-wk Low
$2.24

Chart for

About

Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide... (more)
No analyst recommendations are available for .

Overall

Beta: 2.58
Market Cap(Mil.): $19.23
Shares Outstanding(Mil.): 6.05
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.65 16.44
EPS (TTM): -- -- --
ROI: -- 2.35 10.62
ROE: -- 2.95 14.20

BRIEF-Daré Bioscience announces MoU with CONRAD for conduct of Ovaprene postcoital test clinical trial

* Daré Bioscience, Inc announces memorandum of understanding with Conrad for the conduct of the Ovaprene® postcoital test clinical trial

24 Jul 2017

Earnings vs. Estimates